Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;43(6):624-7.
doi: 10.4103/0253-7613.89814.

Vitamin-C as anti-Helicobacter pylori agent: More prophylactic than curative- Critical review

Affiliations

Vitamin-C as anti-Helicobacter pylori agent: More prophylactic than curative- Critical review

Jagannath Pal et al. Indian J Pharmacol. 2011 Nov.

Abstract

Potential of nonantibiotic therapies for treatment of Helicobacter pylori-related acid peptic disease remains underexplored. Several clinical studies have shown that higher prevalence of H. pylori infection is associated with low Vitamin C (Vit C) level in serum and gastric juice. However, there is no consensus regarding the usefulness of Vit C supplementation in the management of H. pylori infection. Surveying the existing literature we conclude that high concentration of Vit C in gastric juice might inactivate H. pylori urease, the key enzyme for the pathogen's survival and colonization into acidic stomach. Once infection established, urease is not very important for its survival. The role of Vit-C as anti-H. pylori agent in peptic ulcer diseases appears to be preventive rather than curative. Rather than supplementing high dose of Vit C along with conventional triple therapy, it is preferable to complete the conventional therapy and thereafter start Vit C supplementation for extended period which would prevent reinfection in susceptible individuals, provided the patients are not achlorhydric. Further studies are required to prove the role of Vit C in susceptible population.

Keywords: Helicobacter pylori; prophylactic; supplementation; urease; vitamin C.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Inactivation of H. pylori urease by Vit.C in H. pylori-infected gastric mucosa. Abbreviation: Ni – nickel (reduced form), AA- ascorbic acid/Vit. C, DHA- dehydroascorbic acid, HP- H. pylori

Similar articles

Cited by

References

    1. Gisbert JP, Gonzalez L, Calvet X. Systematic review and meta-analysis proton pump inhibitor vs.ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. Helicobacter. 2005;10:157–71. - PubMed
    1. Kamiji MM, de Oliveira RB. Non-antibiotic therapies for Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 2005;17:973–81. - PubMed
    1. Waring AJ, Drake IM, Schorah CJ, White KL, Lynch DA, Axon AT, Dixon MF. Ascorbic acid and total vitamin-C concentrations in plasma, gastric juice, and gastrointestinal mucosa: Effect of gastritis and oral supplementation. Gut. 1996;38:171–6. - PMC - PubMed
    1. Zhang ZW, Patchett SE, Perrett D, Katelaris PH, Domizio P, Farthing MJ. The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut. 1998;43:322–6. - PMC - PubMed
    1. Simon JA, Hudes ES, Perez-Perez GI. Relation of Serum Ascorbic Acid to Helicobacter pylori Serology in US Adults: The Third National Health and Nutrition Examination Survey. J Am Coll Nutr. 2003;22:283–9. - PubMed